BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26121929)

  • 21. Effect of Bayesian-penalized likelihood reconstruction on [13N]-NH3 rest perfusion quantification.
    O' Doherty J; McGowan DR; Abreu C; Barrington S
    J Nucl Cardiol; 2017 Feb; 24(1):282-290. PubMed ID: 27435278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.
    van Ooij P; Allen BD; Contaldi C; Garcia J; Collins J; Carr J; Choudhury L; Bonow RO; Barker AJ; Markl M
    J Magn Reson Imaging; 2016 Jan; 43(1):107-14. PubMed ID: 26227419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.
    Castagnoli H; Ferrantini C; Coppini R; Passeri A; Baldini K; Berti V; Cecchi F; Olivotto I; Sciagrà R
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2413-2422. PubMed ID: 27527796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: comparison of 2 tracer kinetic models.
    Khorsand A; Graf S; Pirich C; Muzik O; Kletter K; Dudczak R; Maurer G; Sochor H; Schuster E; Porenta G
    J Nucl Cardiol; 2005; 12(4):410-7. PubMed ID: 16084429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of PET-measured longitudinal flow gradient for the identification of coronary artery disease.
    Valenta I; Quercioli A; Schindler TH
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):387-96. PubMed ID: 24631507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy.
    Zhao M; Liu M; Leal JP; Tsui BMW; Wong DF; Pomper MG; Zhou Y
    PLoS One; 2019; 14(3):e0212573. PubMed ID: 30893304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
    Timmer SA; Germans T; Brouwer WP; Lubberink M; van der Velden J; Wilde AA; Christiaans I; Lammertsma AA; Knaapen P; van Rossum AC
    Eur J Heart Fail; 2011 Dec; 13(12):1283-9. PubMed ID: 22021246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms.
    Bravo PE; Tahari A; Pozios I; Luo HC; Bengel FM; Wahl RL; Abraham MR; Abraham TP
    J Nucl Cardiol; 2016 Dec; 23(6):1304-1314. PubMed ID: 25989730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy.
    Roldan P; Ravi S; Hodovan J; Belcik JT; Heitner SB; Masri A; Lindner JR
    Cardiovasc Ultrasound; 2022 Sep; 20(1):23. PubMed ID: 36117179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of parametric image of regional myocardial blood flow using H(2)(15)O dynamic PET and a linear least-squares method.
    Lee JS; Lee DS; Ahn JY; Yeo JS; Cheon GJ; Kim SK; Park KS; Chung JK; Lee MC
    J Nucl Med; 2005 Oct; 46(10):1687-95. PubMed ID: 16204719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy.
    Sciagrà R
    Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):354-61. PubMed ID: 27611709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
    Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
    J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of dynamic computed tomography adenosine stress myocardial perfusion imaging in estimating myocardial blood flow at various degrees of coronary artery stenosis using a porcine animal model.
    Bamberg F; Hinkel R; Schwarz F; Sandner TA; Baloch E; Marcus R; Becker A; Kupatt C; Wintersperger BJ; Johnson TR; Theisen D; Klotz E; Reiser MF; Nikolaou K
    Invest Radiol; 2012 Jan; 47(1):71-7. PubMed ID: 22178894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute Myocardial Blood Flow and Flow Reserve Assessed by Gated SPECT with Cadmium-Zinc-Telluride Detectors Using 99mTc-Tetrofosmin: Head-to-Head Comparison with 13N-Ammonia PET.
    Nkoulou R; Fuchs TA; Pazhenkottil AP; Kuest SM; Ghadri JR; Stehli J; Fiechter M; Herzog BA; Gaemperli O; Buechel RR; Kaufmann PA
    J Nucl Med; 2016 Dec; 57(12):1887-1892. PubMed ID: 27363834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13N-ammonia PET/CT.
    Slomka PJ; Alexanderson E; Jácome R; Jiménez M; Romero E; Meave A; Le Meunier L; Dalhbom M; Berman DS; Germano G; Schelbert H
    J Nucl Med; 2012 Feb; 53(2):171-81. PubMed ID: 22228795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy.
    Lu DY; Yalçin H; Yalçin F; Zhao M; Sivalokanathan S; Valenta I; Tahari A; Pomper MG; Abraham TP; Schindler TH; Abraham MR
    Am J Cardiol; 2018 May; 121(9):1081-1089. PubMed ID: 29678336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial blood flow and fibrosis in hypertrophic cardiomyopathy.
    Aquaro GD; Todiere G; Barison A; Strata E; Marzilli M; Pingitore A; Lombardi M
    J Card Fail; 2011 May; 17(5):384-91. PubMed ID: 21549295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical Validation of a Single-Scan Rest/Stress Imaging Technique for
    Guehl NJ; Pelletier-Galarneau M; Wooten DW; Guerrero JL; Kas A; Normandin MD; Fakhri GE; Alpert NM
    Circ Cardiovasc Imaging; 2020 Jan; 13(1):e009407. PubMed ID: 31959009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protocol for measuring myocardial blood flow by PET/CT in cats.
    Jenni SD; Schepis T; Jenni R; Siegrist PT; Kaufmann PA; Glaus TM
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):244-9. PubMed ID: 18818916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.